Last Thursday, the United States Judicial Panel on Multidistrict Litigation (JPML) issued an order consolidating Gardasil human papillomavirus (HPV) vaccine lawsuit claims. The order, according to a press release, allows the cases to move into coordinated discovery and pretrial proceedings.
When cases, like these Gardasil lawsuits, are complex, it is requested that they be moved to one district court. That one court can then handle all discovery and pretrial proceedings for the lawsuits.
Multidistrict Litigation is handled by just one judge during the pretrial and discovery process where it is hoped parties will reach a settlement. If no settlement is reached then cases are sent back to their original courts.
Merck & Co will now have to submit written answers to some very tough questions regarding the number of claims made by plaintiffs.
On granting the consolidation of Gardasil human papillomavirus (HPV) vaccine lawsuit claims, the United States Judicial Panel on Multidistrict Litigation said, "These personal injury actions present common questions of fact arising from allegations that plaintiffs, or their minor children, developed postural orthostatic tachycardia syndrome (POTS) and various other injuries as the result of an autoimmune reaction to the Gardasil vaccine…"
Baum Hedlund Aristei & Goldman, are representing young men and women across the country who allege they suffered serious injuries as a result of Gardasi, injuries that include but are not limited to:
Autonomic Dysfunction (Dysautonomia)
Complex Regional Pain Syndrome (CRPS)
Premature Ovarian Failure (POF)
Fibromyalgia
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS)
Orthostatic Intolerance (OI)
Postural Orthostatic Tachycardia Syndrome (POTS)
By July 28, 2022, 48 cases were pending with at least 100 more to be filed in federal courts nationwide. You can read about some of these cases below:
"I don’t want this pain for other kids." ~ Victoria Trevisan, Gardasil Victim
Bob Fiddaman
No comments: